Biotech Stock Roundup: Juno-Celgene In Immunotherapy Deal …

The Celgene Corporation (CELG – Analyst Report) – Juno Therapeutics’ (JUNO – Analyst Report) immunotherapy deal worth at least a billion dollars was the main story in the biotech sector this week. While concerns are being raised about the high price tag, the deal just goes to show the growing interest in the field of immunotherapy. Meanwhile, quite a few […]

Toxic Markets Are Everywhere. Here’s the Safest Place for Your Money Today…

Have you come out of your bunker yet after Monday’s Greek tragedy?You might have expected more fireworks yesterday after Monday’s 350-point rout. But the Dow managed to gain 23 points and the Nasdaq tacked on 28.So where do we stand right now? And what should you do with your money today?I’m going to tell you…But before we get to my […]

Market Takes a Breath

Premier Membership: Live Stock Trade Alerts to Buy & Sell with JoeThis is where the majority of our members come to. FOR $99/month or $799 (1 installment) you become a member of an exclusive group of traders wanting to tap into this powerful resource on a daily, if not hourly, basis.  In addition to the educational videos, weeknight market recaps, […]

Stocks Turmoil To End Q2 With Worst Run Since Lehman

Overheard at The PBOC, The SNB, The ECB, and The Fed…Before we start, it is worth noting that this is the first consecutive quarterly loss for Trannies since Lehman…S&P 2067.89 was all that mattered today – for the biggest US equity market to avoid its first quarterly loss since Q4 2012… It Failed!!Q2 ends with crude the big winner, bonds […]

5 Biotech Stocks On Deck With The FDA – Benzinga

Some traders like to gamble on big news events that could have a dramatic effect on a particular stock. For example, the release of a company’s earnings report could cause an underlying stock to jump to new highs or drop to significant lows. While this may not interest all investors, it does prove to be a point of intrigue for […]

Biotech Stock News (EPZM) (VICL) (ALPMF) (CBLI) | CNA Finance

Epizyme (NASDAQ:EPZM)On June 22, 2015 shares of Epizyme were up about 27% after the company announced that it had obtained positive phase 1 results in patients with Non-Hodgkin’s Lymphoma — NHL. The company used its drug known as EPZ-6438, which is also known as tazemetostat to treat these patients with NHL. Epizyme has developed this drug to treat these NHL […]

Biotech Stocks Lose Momentum with Greece Crisis; Blockbuster Immunotherapy Deal

Biotech Stocks in Broad Sell-Off
The biotech sector is usually immune to macro events but today the crisis in Greece gave investors an excuse to take profits. Many biotech stocks and ETFs were down over 3% faring worse than the NASDAQ down 2.4%. The sector, as tracked by IBB, is still up 18.87% YTD after hitting a high of 383 on […]